Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis

被引:49
作者
Dalboge, C. S. [1 ]
Hansen, C. R. [2 ]
Pressler, T. [2 ]
Hoiby, N. [1 ,3 ]
Johansen, H. K. [1 ]
机构
[1] Univ Copenhagen, Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen O, Denmark
[2] Univ Copenhagen, Rigshosp, Copenhagen Cyst Fibrosis Ctr, DK-2100 Copenhagen O, Denmark
[3] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, DK-2100 Copenhagen O, Denmark
关键词
Stenotrophomonas maltophilia; Cystic fibrosis; Lung infection; PSEUDOMONAS-AERUGINOSA; EMERGING PATHOGENS; RISK-FACTORS; XYLOSOXIDANS; COLONIZATION; EPIDEMIOLOGY; CEPACIA;
D O I
10.1016/j.jcf.2011.03.006
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The clinical consequences of chronic Stenotrophomonas maltophilia infection in cystic fibrosis (CF) patient are still unclear. Method: All patients treated in the Copenhagen CF centre (N=278) from 1 January 2008 to 31 December 2009 were included. Each patient chronically infected with S. maltophilia for at least 2 years without any other chronic Gram-negative infection were matched to two non-infected CF controls. Results: Twenty-one patients were chronically infected with S. maltophilia during the 2-year study period. Fifteen were infected for at least 2 years. The patients in the S. maltophilia group had a steeper decline (-3.2%/year vs. -0.3%/year) in FEV1 compared to the non-infected CF controls (P=0.03). The rate of decline was the same as observed 3 years before the patients became chronically infected. Discussions: Chronic infection with S. maltophilia does not lead to a steeper decline in lung function when compared to the period before chronic infection. (C) 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:318 / 325
页数:8
相关论文
共 31 条
[1]  
[Anonymous], 2000, CYSTIC FIBROSIS
[2]   STENOTROPHOMONAS MALTOPHILIA IN CYSTIC-FIBROSIS PATIENTS [J].
BALLESTERO, S ;
VIRSEDA, I ;
ESCOBAR, H ;
SUAREZ, L ;
BAQUERO, F .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (08) :728-729
[3]  
Demko CA, 1998, PEDIATR PULM, V25, P304, DOI 10.1002/(SICI)1099-0496(199805)25:5<304::AID-PPUL3>3.3.CO
[4]  
2-K
[5]   Changes in Cystic Fibrosis Sputum Microbiology in the United States Between 1995 and 2008 [J].
Emerson, Julia ;
McNamara, Sharon ;
Buccat, Anne Marie ;
Worrell, Kelly ;
Burns, Jane L. .
PEDIATRIC PULMONOLOGY, 2010, 45 (04) :363-370
[6]   CONTROLLED-STUDY OF PSEUDOMONAS-CEPACIA AND PSEUDOMONAS-MALTOPHILIA IN CYSTIC-FIBROSIS [J].
GLADMAN, G ;
CONNOR, PJ ;
WILLIAMS, RF ;
DAVID, TJ .
ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (02) :192-195
[7]   Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis [J].
Goss, CH ;
Mayer-Hamblett, N ;
Aitken, ML ;
Rubenfeld, GD ;
Ramsey, BW .
THORAX, 2004, 59 (11) :955-959
[8]   Factors affecting the incidence Stenotrophomonas maltophilia isolation in cystic fibrosis [J].
Graff, GR ;
Burns, JL .
CHEST, 2002, 121 (06) :1754-1760
[9]   Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients;: a retrospective case control study [J].
Hansen, Christine Ronne ;
Pressler, Tacjana ;
Hoiby, Niels ;
Gormsen, Magdalena .
JOURNAL OF CYSTIC FIBROSIS, 2006, 5 (04) :245-251
[10]  
Hoiby N, 2006, EUR RESPIR MONOGR, P66